It’s always prudent to rely on yourself to find out how safe and effective a drug you were prescribed is.
I do Not support going off medications without checking with your medical doctors.
I’ve never had a doctor, pharmacist, or nurse offer me information to let me know that the Food & Drug Administration (FDA) in the United States has made changes in labeling of the medications/drugs they peddle (I prefer to call them drugs because that’s what they are) any more than the American Psychiatric Association made it possible for me to know that my treatment for multiple personalities and the methods used to enhance recall or alleged abuse memories were in question.
I can only wonder what difference access to information would have made in my life during MPD/DID treatment. But denying access to information is one of the best ways some psychiatrists – and cults – keep people ignorant and in the fold. It would Not have taken nearly 7 years and huge risks to my physical and mental health to escape therapy. Armed with knowledge and information would have provided me with the ability to make an informed decision about my mental health care. At that point, I would have run for the hills.
I came across this website by the FDA – never knew it existed. This is one-stop-shopping to find out what changes the Food and Drug Administration (FDA) has made regarding many drugs currently on the market. These drugs may be in your medicine closet, your body, or in your child or other family member’s body as well.
It has been established for decades that there are no drugs to cure or effectively treat multiple personalities and/or dissociative identity disorder. The best psychiatrists can do is prescribe drugs to alleviate symptoms like anxiety, insomnia, psychotic-like behavior and thinking, obsessive/compulsive disorders, and others. If you are interested in knowing what people diagnosed with multiple personalities are prescribed, do a quick Internet search and read discussions in forums under: survivors, abuse survivors, trauma survivors, dissociation, DID and related topics. There is always a conversation going on somewhere about the drugs this population consumes.
From the Food & Drug Administration Newsletter Vol 86, October 2011 Retrieved 11/02/11.
This is a summary of the FDA drug labeling changes for September 2011. Click on a drug name to view the changes in more detail.
Included in this updated newsletter include: adverse reactions, contraindications, patient package inserts, medication guide, precautions, patient counseling information and warnings.